MedTrace Logo

Effects of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

NCT00668876 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether immunonutrition is effective on surgical site infection and Th1/Th2/Th17 differentiation in patients undergoing pancreaticoduodenectomy

Conditions

  • Pancreaticoduodenectomy

Interventions

DIETARY_SUPPLEMENT

Oral IMPACT

oral supplementation for 5 days(1 L/d )before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA

DIETARY_SUPPLEMENT

Oral IMPACT

postoperative enteral infusion of the formula with arginine, omega-3 fatty acids, and RNA

DIETARY_SUPPLEMENT

Parenteral nutrition

Parenteral nutrition

Sponsors & Collaborators

  • Chiba University

    lead OTHER

Principal Investigators

  • Daisuke Suzuki · Chiba University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2008-01-31
Completion
2008-09-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00668876 on ClinicalTrials.gov